The use of live attenuated bacteria as a delivery system for heterologous antigens

Garmory, HS; Leary, SEC; Griffin, KF; Williamson, ED; Brown, KA; Titball, RW; (2004) The use of live attenuated bacteria as a delivery system for heterologous antigens. Journal of drug targeting, 11 (8-10). p. 471. ISSN 1061-186X DOI:

Full text not available from this repository.


Live attenuated mutants of several pathogenic bacteria have been exploited as potential vaccine vectors for heterologous antigen delivery by the mucosal route. Such live vectors offer the advantage of potential delivery in a single oral, intranasal or inhalational dose, stimulating both systemic and mucosal immune responses. Over the years, a range of strategies have been developed to allow controlled and stable delivery of antigens and improved immunogenicity where required. Most of these approaches have been evaluated in Salmonella vaccine vectors and, as a result, several live attenuated recombinant Salmonella vaccines are now in human clinical trials. In this review, these strategies and their use in the development of a delivery system for the Yersinia pestis V antigen are described.

Item Type: Article
Keywords: attenuated bacteria, heterologous antigen, vaccine, V antigen, Toxin fragment-c, enterotoxigenic escherichia-coli, immunodeficiency-virus type-1, recombinant salmonella-dublin, typhimurium vaccine strain, glutathione-s-transferase, pestis, v-antigen, yersinia-pestis, tetanus toxin, bordetella-pertussis
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
Web of Science ID: 220717000003


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item